Literature DB >> 4022360

Myasthenic crisis after intravenous administration of iodinated contrast agent.

Y Chagnac, M Hadani, Y Goldhammer.   

Abstract

Two women with myasthenia gravis became apneic immediately after IV injection of iodinated contrast material for CT. Aggravation of myasthenia continued for days after this initial reaction.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4022360     DOI： 10.1212/wnl.35.8.1219

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

1.  Antipyretic therapy in intensive care.

Authors:  D F Zandstra; C P Stoutenbeek
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

2.  Myasthenic crisis during intravenous iodinated contrast medium injection.

Authors:  G P Anzola; R Capra; M Magoni; L A Vignolo
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 3.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

4.  Myasthenia gravis: a review.

Authors:  Annapurni Jayam Trouth; Alok Dabi; Noha Solieman; Mohankumar Kurukumbi; Janaki Kalyanam
Journal:  Autoimmune Dis       Date:  2012-10-31

Review 5.  Myasthenia gravis.

Authors:  Vern C Juel; Janice M Massey
Journal:  Orphanet J Rare Dis       Date:  2007-11-06       Impact factor: 4.123

6.  Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study.

Authors:  Jakob Rath; Matthias Mauritz; Gudrun Zulehner; Eva Hilger; Hakan Cetin; Gregor Kasprian; Eduard Auff; Fritz Zimprich
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.